Related Experiment Video
Updated: Aug 7, 2026
08:16
Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
Published on: March 4, 2014
New pathological findings in amyotrophic lateral sclerosis
1Department of Pathology, University of Nottingham Medical School, Queen's Medical Centre, UK.
Journal of the Neurological Sciences
|July 1, 1994
Summary
Recent findings reveal a specific ubiquitin-positive inclusion in sporadic Amyotrophic Lateral Sclerosis (ALS) pathology. This multisystem disease impacts non-motor functions, suggesting broader implications for ALS research.
Area of Science:
- Neuroscience
- Neuropathology
- Genetics
Background:
- Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disease primarily affecting motor neurons.
- Recent research indicates ALS pathology extends beyond motor systems, involving non-motor functions and subcortical structures in long-term survivors.
- Evidence suggests ALS may manifest as a non-motor syndrome, such as frontal lobe dementia, with distinct pathological inclusions.
Purpose of the Study:
- To characterize a newly identified filamentous neuronal inclusion body in sporadic ALS.
- To investigate the specificity of this inclusion for ALS.
- To explore the implications of ALS being a multisystem disease for understanding its pathogenesis.
Main Methods:
- Immunohistochemical localization of ubiquitin to identify the inclusion body.
- Light microscopic and ultrastructural characterization of the inclusion.
- Review of accumulating evidence on ALS's involvement in non-motor systems.
Main Results:
- A novel filamentous neuronal inclusion, detected via ubiquitin immunohistochemistry, has been identified and characterized.
- This inclusion appears to be specific to Amyotrophic Lateral Sclerosis (ALS).
- ALS is increasingly recognized as a multisystem disorder affecting both motor and non-motor pathways.
Conclusions:
- The newly characterized ubiquitin-positive inclusion is a significant finding in sporadic ALS pathology.
- Understanding ALS as a multisystem disease is crucial for advancing research into its pathogenesis.
- Further research is needed to determine the molecular composition of the inclusion filaments.
Related Concept Videos
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...